Co-culture platform for tuning of cancer receptor density allows for evaluation of bispecific immune cell engagers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-culture platform for tuning of cancer receptor density allows for evaluation of bispecific immune cell engagers

Published:2024-03 Issue: Volume:79 Page:120-126
ISSN:1871-6784
Container-title:New Biotechnology
language:en
Short-container-title:New Biotechnology

Author:

Mebrahtu Aman,Aniander Gustav,Mega Alessandro,Moradi Barzadd Mona,Berndt Thalén Niklas,Gudmundsdotter Lindvi,Backström Rydin Eva,Sandegren Anna,Frejd Fredrik Y.,Rockberg Johan

Funder

VINNOVA

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Bioengineering,Biotechnology

Reference31 articles.

1. The future of cancer immunotherapy: microenvironment-targeting combinations;Murciano-Goroff;Cell Res,2020

2. Mechanisms of resistance to immune checkpoint inhibitors;Jenkins;Br J Cancer,2018

3. Combination of Ipilimumab and nivolumab in cancers: from clinical practice to ongoing clinical trials;Kooshkaki;Int J Mol Sci,2020

4. Immune checkpoint inhibitors: recent progress and potential biomarkers;Darvin;Exp Mol Med,2018

5. Bispecific antibodies in cancer immunotherapy;Dahlén;Ther Adv Vaccin Immunother,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage display technology and its impact in the discovery of novel protein-based drugs;Expert Opinion on Drug Discovery;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP